Donaldson Capital Management, LLC Eli Lilly & CO Transaction History

Donaldson Capital Management, LLC

$2.59 Billion
Q3 2024

A detailed history of Donaldson Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Donaldson Capital Management, LLC holds 22,806 shares of LLY stock, worth $17.9 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

22,806

Previous 26,053 12.46%

Holding current value

$17.9 Million

Previous $23.6 Million 14.34%

% of portfolio

0.78%

Previous 0.99%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$772.14 - $960.02 $2.51 Million - $3.12 Million	-3,247 Reduced 12.46%	22,806 $20.2 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $306,620 - $384,523	423 Added 1.65%	26,053 $23.6 Million
Q1 2024 Apr 22, 2024	BUY	$592.2 - $792.28 $1.57 Million - $2.1 Million	2,651 Added 11.54%	25,630 $19.9 Million
Q4 2023 Jan 30, 2024	SELL	$525.19 - $619.13 $9.08 Million - $10.7 Million	-17,292 Reduced 42.94%	22,979 $13.4 Million
Q3 2023 Oct 11, 2023	SELL	$434.7 - $599.3 $88,244 - $121,657	-203 Reduced 0.5%	40,271 $21.6 Million
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $458,417 - $612,956	-1,307 Reduced 3.13%	40,474 $19 Million
Q1 2023 Apr 13, 2023	SELL	$310.63 - $364.82 $1.65 Million - $1.94 Million	-5,314 Reduced 11.28%	41,781 $14.3 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $823,489 - $959,529	2,561 Added 5.75%	47,095 $17.2 Million
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $756,024 - $861,568	2,550 Added 6.07%	44,534 $14.4 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $17,559 - $20,618	-63 Reduced 0.15%	41,984 $13.6 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $134,712 - $167,412	574 Added 1.38%	42,047 $12 Million
Q4 2021 Jan 21, 2022	SELL	$224.85 - $279.04 $101,857 - $126,405	-453 Reduced 1.08%	41,473 $11.5 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $66,701 - $82,085	-301 Reduced 0.71%	41,926 $9.69 Million
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $1.19 Million - $1.53 Million	-6,570 Reduced 13.46%	42,227 $9.69 Million
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $98,263 - $127,206	598 Added 1.24%	48,797 $9.12 Million
Q4 2020 Jan 11, 2021	SELL	$130.46 - $172.63 $25,178 - $33,317	-193 Reduced 0.4%	48,199 $8.14 Million
Q3 2020 Nov 02, 2020	SELL	$146.22 - $169.13 $159,087 - $184,013	-1,088 Reduced 2.2%	48,392 $7.16 Million
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $125,233 - $150,717	918 Added 1.89%	49,480 $8.12 Million
Q1 2020 Apr 16, 2020	BUY	$119.05 - $147.35 $300,244 - $371,616	2,522 Added 5.48%	48,562 $6.74 Million
Q4 2019 Jan 14, 2020	BUY	$106.92 - $132.43 $2.21 Million - $2.74 Million	20,705 Added 81.72%	46,040 $6.05 Million
Q3 2019 Nov 04, 2019	BUY	$106.79 - $116.16 $2.11 Million - $2.29 Million	19,745 Added 353.22%	25,335 $2.83 Million
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $19,499 - $22,760	176 Added 3.25%	5,590 $619,000
Q1 2019 Apr 01, 2019	SELL	$111.31 - $131.02 $80,143 - $94,334	-720 Reduced 11.74%	5,414 $703,000
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $15,885 - $17,796	-150 Reduced 2.39%	6,134 $710,000
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $9,187 - $11,482	-107 Reduced 1.67%	6,284 $674,000
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $7,570 - $8,688	-100 Reduced 1.54%	6,391 $545,000
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $25,973 - $30,659	-350 Reduced 5.12%	6,491 $502,000
Q4 2017 Jan 30, 2018	BUY	$81.94 - $87.89 $560,551 - $601,255	6,841 New	6,841 $578,000
Q4 2017 Jan 26, 2018	SELL	$81.94 - $87.89 $526,710 - $564,956	-6,428 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $495,405 - $549,851	6,428	6,428 $550,000

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donaldson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donaldson Capital Management, LLC with notifications on news.

Account

Donaldson Capital Management, LLC Eli Lilly & CO Transaction History